134 related articles for article (PubMed ID: 30017671)
21. The subsequent risk of internal cancer with Bowen's disease. A population-based study.
Chute CG; Chuang TY; Bergstralh EJ; Su WP
JAMA; 1991 Aug; 266(6):816-9. PubMed ID: 1865520
[TBL] [Abstract][Full Text] [Related]
22. Superficial basal cell carcinoma mimicking Bowen's disease: Diagnosis with noninvasive imaging.
Chen KJ; Wang ZY; Han Y; Cui Y
Skin Res Technol; 2023 Apr; 29(4):e13316. PubMed ID: 37113083
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence diagnosis and photodynamic therapy for Bowen's disease treatment.
Truchuelo MT; Pérez B; Fernández-Guarino M; Moreno C; Jaén-Olasolo P
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):86-93. PubMed ID: 23331846
[TBL] [Abstract][Full Text] [Related]
24. Shining into the White: The Spectrum of Epithelial Tumors from Actinic Keratosis to Squamous Cell Carcinoma.
Ulrich M; Zalaudek I; Welzel J
Dermatol Clin; 2016 Oct; 34(4):459-467. PubMed ID: 27692451
[TBL] [Abstract][Full Text] [Related]
25. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.
Usmani N; Stables GI; Telfer NR; Stringer MR
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S273-6. PubMed ID: 16227107
[TBL] [Abstract][Full Text] [Related]
26. Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection.
Hambly R; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
Br J Dermatol; 2017 Sep; 177(3):e55-e57. PubMed ID: 28028807
[No Abstract] [Full Text] [Related]
27. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
28. Hypomelanotic melanoma simulating pigmented Bowen's disease and its challenging dermoscopic features.
Ogawa S; Namiki T; Uchida C; Nojima K; Miura K; Tanaka M; Yokozeki H
J Dermatol; 2019 May; 46(5):e173-e175. PubMed ID: 30353916
[No Abstract] [Full Text] [Related]
29. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence spectroscopy as a tool to in vivo discrimination of distinctive skin disorders.
Maciel VH; Correr WR; Kurachi C; Bagnato VS; da Silva Souza C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():45-50. PubMed ID: 28363758
[TBL] [Abstract][Full Text] [Related]
31. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
Peris K; Micantonio T; Fargnoli MC; Lozzi GP; Chimenti S
J Am Acad Dermatol; 2006 Aug; 55(2):324-7. PubMed ID: 16844522
[TBL] [Abstract][Full Text] [Related]
32. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
33. Squamous Cell Carcinoma Following Photodynamic Therapy for Cutaneous Bowen's Disease in a Series of 105 Patients.
Ratour-Bigot C; Chemidling M; Montlahuc C; Abirached G; Madjlessi N; Bullier C; Battistella M; Bagot M; Lebbe C; Basset-Seguin N
Acta Derm Venereol; 2016 Jun; 96(5):658-63. PubMed ID: 26714426
[TBL] [Abstract][Full Text] [Related]
34. Bowen's disease of the penile shaft presenting as a pigmented macule: dermoscopy, reflectance confocal microscopy and histopathological correlation.
Lacarrubba F; Verzì AE; Caltabiano R; Micali G
An Bras Dermatol; 2021; 96(5):609-612. PubMed ID: 34284940
[TBL] [Abstract][Full Text] [Related]
35. Enhanced visualization of blood and pigment in multispectral skin dermoscopy.
Janssen L; Mylle S; Van Kelst S; De Smedt J; Diricx B; Kimpe T; Boone M; Verhaeghe E; Brochez L; Garmyn M
Skin Res Technol; 2020 Sep; 26(5):708-712. PubMed ID: 32227367
[TBL] [Abstract][Full Text] [Related]
36. The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers.
Hewett J; Nadeau V; Ferguson J; Moseley H; Ibbotson S; Allen JW; Sibbett W; Padgett M
Photochem Photobiol; 2001 Mar; 73(3):278-82. PubMed ID: 11281024
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of diagnostic values of photodynamic diagnosis in identifying the dermal and mucosal squamous cell carcinoma.
Kamrava SK; Behtaj M; Ghavami Y; Shahabi S; Jalessi M; Afshar EE; Maleki S
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):293-8. PubMed ID: 23200008
[TBL] [Abstract][Full Text] [Related]
38. [The wider application of photodynamic therapy in dermatology].
Thissen MR; Kuijpers DI; Neumann HA
Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy for non-melanoma skin cancer.
Szeimies RM; Morton CA; Sidoroff A; Braathen LR
Acta Derm Venereol; 2005; 85(6):483-90. PubMed ID: 16396794
[TBL] [Abstract][Full Text] [Related]
40. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
